Vanguard Group’s Pfizer PFE Stock Holding History

Vanguard Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$12.9B	Buy	533,363,457 +10,198,330	+2%	+$247M	0.21%	82
2025 Q1	$13.3B	Buy	523,165,127 +4,629,976	+0.9%	+$117M	0.24%	70
2024 Q4	$13.8B	Buy	518,535,151 +2,285,276	+0.4%	+$60.6M	0.24%	62
2024 Q3	$14.9B	Buy	516,249,875 +4,846,835	+0.9%	+$140M	0.27%	58
2024 Q2	$14.3B	Buy	511,403,040 +4,149,159	+0.8%	+$116M	0.27%	52
2024 Q1	$14.1B	Buy	507,253,881 +736,415	+0.1%	+$20.4M	0.28%	55
2023 Q4	$14.6B	Sell	506,517,466 -210,463	-0%	-$6.06M	0.32%	46
2023 Q3	$16.8B	Sell	506,727,929 -1,366,155	-0.3%	-$45.3M	0.41%	32
2023 Q2	$18.6B	Sell	508,094,084 -313,891	-0.1%	-$11.5M	0.44%	30
2023 Q1	$20.7B	Buy	508,407,975 +6,771,755	+1%	+$276M	0.53%	25
2022 Q4	$25.7B	Buy	501,636,220 +8,051,459	+2%	+$413M	0.7%	19
2022 Q3	$21.6B	Buy	493,584,761 +5,139,634	+1%	+$225M	0.64%	20
2022 Q2	$25.6B	Buy	488,445,127 +9,379,854	+2%	+$492M	0.72%	17
2022 Q1	$24.8B	Buy	479,065,273 +13,790,348	+3%	+$714M	0.59%	19
2021 Q4	$27.5B	Buy	465,274,925 +5,332,622	+1%	+$315M	0.62%	16
2021 Q3	$19.8B	Buy	459,942,303 +3,738,673	+0.8%	+$161M	0.49%	25
2021 Q2	$17.9B	Buy	456,203,630 +5,289,511	+1%	+$207M	0.44%	28
2021 Q1	$16.3B	Buy	450,914,119 +2,955,372	+0.7%	+$107M	0.44%	35
2020 Q4	$16.5B	Sell	447,958,747 -27,475,027	-6%	-$1.01B	0.48%	29
2020 Q3	$16.6B	Sell	475,433,774 -6,132,352	-1%	-$214M	0.55%	29
2020 Q2	$14.9B	Sell	481,566,126 -5,357,209	-1%	-$166M	0.53%	29
2020 Q1	$15.1B	Buy	486,923,335 +12,666,307	+3%	+$392M	0.64%	20
2019 Q4	$17.6B	Buy	474,257,028 +4,709,590	+1%	+$175M	0.6%	24
2019 Q3	$16B	Buy	469,547,438 +360,030	+0.1%	+$12.3M	0.59%	26
2019 Q2	$19.3B	Sell	469,187,408 -5,106,763	-1%	-$210M	0.73%	14
2019 Q1	$19.1B	Sell	474,294,171 -1,697,438	-0.4%	-$68.4M	0.75%	15
2018 Q4	$19.7B	Buy	475,991,609 +10,341,820	+2%	+$428M	0.89%	11
2018 Q3	$19.5B	Buy	465,649,789 +6,978,269	+2%	+$292M	0.76%	13
2018 Q2	$15.8B	Sell	458,671,520 -4,390,034	-0.9%	-$151M	0.66%	19
2018 Q1	$15.6B	Buy	463,061,554 +6,670,903	+1%	+$225M	0.68%	17
2017 Q4	$15.7B	Buy	456,390,651 +8,403,279	+2%	+$289M	0.69%	17
2017 Q3	$15.2B	Buy	447,987,372 +6,741,749	+2%	+$228M	0.71%	16
2017 Q2	$14.1B	Buy	441,245,623 +9,738,432	+2%	+$310M	0.69%	17
2017 Q1	$14B	Buy	431,507,191 +7,684,524	+2%	+$249M	0.72%	17
2016 Q4	$13.1B	Buy	423,822,667 +9,285,790	+2%	+$286M	0.73%	18
2016 Q3	$13.3B	Buy	414,536,877 +10,497,030	+3%	+$337M	0.78%	15
2016 Q2	$13.5B	Buy	404,039,847 +6,528,288	+2%	+$218M	0.84%	14
2016 Q1	$11.2B	Buy	397,511,559 +10,006,436	+3%	+$281M	0.72%	18
2015 Q4	$11.9B	Buy	387,505,123 +8,742,720	+2%	+$268M	0.8%	15
2015 Q3	$11.3B	Buy	378,762,403 +5,237,922	+1%	+$156M	0.82%	13
2015 Q2	$11.9B	Buy	373,524,481 +1,750,945	+0.5%	+$55.7M	0.8%	11
2015 Q1	$12.3B	Buy	371,773,536 +9,382,235	+3%	+$310M	0.83%	11
2014 Q4	$10.7B	Buy	362,391,301 +10,346,730	+3%	+$306M	0.77%	12
2014 Q3	$9.88B	Buy	352,044,571 +6,348,838	+2%	+$178M	0.77%	15
2014 Q2	$9.73B	Buy	345,695,733 +5,853,402	+2%	+$165M	0.77%	14
2014 Q1	$10.4B	Buy	339,842,331 +3,272,079	+1%	+$99.7M	0.87%	12
2013 Q4	$9.78B	Sell	336,570,252 -2,374,957	-0.7%	-$69M	0.86%	12
2013 Q3	$9.23B	Buy	338,945,209 +4,073,436	+1%	+$111M	0.9%	12
2013 Q2	$8.9B	Buy	+334,871,773	New	+$8.9B	0.93%	13